Global respiratory equipment market poised to hit $21 billion by 2010
15 January 2006
With the international incidence of asthma and chronic obstructive
pulmonary disease (COPD) surpassing 314 million, and an aging world
population increasingly succumbing to respiratory illness, the stage is set
for the global market for disposable and reusable respiratory equipment to
reach $21 billion by 2010, according to The World Market for Respiratory
Equipment study released by Kalorama Information. The U.S. market, with its
approximately 20 million asthma sufferers accounting for 60% of the world
market, alone anticipates sales of $10 billion this year.
This new report predicts that along with the worldwide population shift,
regulatory changes will drive growth in this market, which has seen little
innovation in recent years. The U.S. government ban on chlorofluorocarbons
(CFCs) starting in January 2008 will change the face of the more than 95% of
inhalers available on the market to treat asthma, COPD, and emphysema.
Inhalers dominate the respiratory equipment market with 70% of sales.
This, along with increased coverage of Medicare patients through the
Medicare Modernization Act (MMA) in the USA and growing coverage of
international patient groups, will help to assure industry growth.
"We should see incremental industry-wide growth as manufacturers continue
to increase their global presence, particularly in Asia, and increase their
R&D efforts to bring new products — such as combination agents that will
reduce the usage of single use/multiple dose agents — to the global
marketplace," notes Joseph Constance, the supervising analyst for the final
The World Market for Respiratory Equipment provides a holistic view of
the disposable and reusable respiratory equipment industry; discusses key
trends and industry challenges; analyzes innovations and strategies for key
market sectors; and includes insights into the worldwide market potential.
For more information visit the Kalorama website at